- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07938788
Impact of Dietary Diversity on Postprandial Insulin Secretion and Metabolism
This randomized, controlled, crossover dietary intervention will test whether a three-week diverse diet, compared with a control diet with lower food diversity, changes postprandial insulin responses, other metabolic parameters, and the gut microbiome in 34 healthy adults with overweight. Participants will complete both diets in a randomized order, separated by a four-week washout period. The intervention periods will be conducted under free-living conditions, with study foods provided by the research center. Before and after each intervention period, postprandial metabolism will be assessed using standardized meal tests conducted under controlled whole-room calorimetry conditions. The primary outcome is the log-transformed total postprandial insulin area under the concentration-time curve from 0 to 240 minutes.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Anja Bosy-Westphal, Prof. Dr. Dr.
- Numéro de téléphone: +49 431 880 5674
- E-mail: abosyw@nutrition.uni-kiel.de
Lieux d'étude
-
-
Schleswig-Holstein
-
Kiel, Schleswig-Holstein, Allemagne, 24105
- Institute of Human Nutrition and Food Science , Department Human Nutrition
-
Contact:
- Anja Bosy-Westphal
- Numéro de téléphone: +49 431 880 5674
- E-mail: abosyw@nutrition.uni-kiel.de
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Healthy adults with overweight.
- Age 18-60 years.
- Body mass index (BMI) >=25 and <30 kg/m2.
- Men and women; the study plans an equal distribution of biological sex.
- No regular sports participation; regular sporting activity >=2 h/week is excluded.
- German-speaking, because the study questionnaires are in German and not validated in other languages.
- No anemia or iron deficiency based on screening hemoglobin and ferritin.
- Women of childbearing potential must use hormonal contraception (e.g., pill, hormonal IUD, contraceptive patch, vaginal ring, 3-month injection, or hormonal implant) and have pregnancy excluded by hCG testing.
- Able and willing to provide written informed consent.
Exclusion Criteria:
- - Individuals unable to provide informed written consent.
- Vegetarian or vegan diet.
- Habitual consumption of more than 5 caffeinated beverages per day.
- Chronic diseases.
- Regular medication use, except oral contraceptives.
- Antibiotic use within 6 weeks before study start.
- Anemia and/or iron deficiency.
- Pregnancy or breastfeeding.
- Cigarette and/or cannabis use, including vaping.
- Food allergies and/or food intolerances.
- Current weight-reduction diet or weight loss >5 kg within the previous 3 months.
- Regular sporting activity >=2 h/week.
- Claustrophobia/fear of confined spaces because of EchoMRI assessment.
- Active participation in another study.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation croisée
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Control Diet -> Diverse Diet
|
Three-week controlled free-living diet with low diversity of plant foods, lower diversity/content of fiber types and polyphenols, fewer fermented foods, and at least 50% of energy from ultra-processed foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to a diverse diet. Three-week controlled free-living diet with a wide variety of minimally processed plant foods, different fiber types and polyphenol sources, and regularly consumed fermented foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to the control diet. |
|
Expérimental: Diverse Diet -> Control Diet
|
Three-week controlled free-living diet with low diversity of plant foods, lower diversity/content of fiber types and polyphenols, fewer fermented foods, and at least 50% of energy from ultra-processed foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to a diverse diet. Three-week controlled free-living diet with a wide variety of minimally processed plant foods, different fiber types and polyphenol sources, and regularly consumed fermented foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to the control diet. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Postprandial Insulin
Délai: 0-240 minutes
|
fasting, iAUC, tAUC, peak - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Postprandial Glucose
Délai: 0-240 minutes
|
fasting, iAUC, tAUC, peak - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
|
C-Peptide
Délai: 24 hours
|
Urinary c-peptide excretion during the 24h stay in the whole-room indirect calorimeter. |
24 hours
|
|
Non-esterified fatty acids
Délai: 0-240 minutes
|
fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
|
Triglycerides
Délai: 0-240 minutes
|
fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
|
Appetite-relatied hormones (GLP-1, PYY, Ghrelin)
Délai: 0-240 minutes
|
fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
|
Subjective Appetite
Délai: 0-300 minutes
|
measured with visual analogue scales (5 hours AUC; mm x 5 hours) after a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. The scale consists of a 10 cm vertical line anchored with "not hungry at all" at the left side and with "extremely hungry" at the right side. |
0-300 minutes
|
|
Energy Expenditure and macronutrient oxidation
Délai: 24 hours
|
measured during the 24h stay with indirect calorimetry in a whole-room indirect calorimeter (kcal/day) at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
24 hours
|
|
Gut microbiome composition and Microbiome diversity
Délai: Baseline, after 1 week in the intervention (day 8), after the 3-week intervention (day 21) - in both arms.
|
taxonomy and function via shotgun metagenome sequencing |
Baseline, after 1 week in the intervention (day 8), after the 3-week intervention (day 21) - in both arms.
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- ABW-2026-GRK
- 54453043/GRK3128 (Autre subvention/numéro de financement: DFG)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .